数据归一化算法

2017-10-12 MedSci MedSci原创

数据标准化(归一化)处理是数据挖掘的一项基础工作,不同评价指标往往具有不同的量纲和量纲单位,这样的情况会影响到数据分析的结果,为了消除指标之间的量纲影响,需要进行数据标准化处理,以解决数据指标之间的可比性。原始数据经过数据标准化处理后,各指标处于同一数量级,适合进行综合对比评价。 数据归一化? 数据标准化(归一化)处理是在数据挖掘中的一项常见的预处理任务,很多情况下当你在数据预处理时都会浮现出

数据标准化(归一化)处理是数据挖掘的一项基础工作,不同评价指标往往具有不同的量纲和量纲单位,这样的情况会影响到数据分析的结果,为了消除指标之间的量纲影响,需要进行数据标准化处理,以解决数据指标之间的可比性。原始数据经过数据标准化处理后,各指标处于同一数量级,适合进行综合对比评价。 数据归一化? 数据标准化(归一化)处理是在数据挖掘中的一项常见的预处理任务,很多情况下当你在数据预处理时都会浮现出一个问题,是不是要进行数据标准化处理? 一般来说,数据归一化后有一个很明显的优点,最优解的寻优过程明显会变得平缓,更容易正确的收敛到最优解。 归一化前 归一化后 以下是常用的归一化方法: 一、min-max标准化(Min-Max Normalization),也称0-1标准化(0-1 normalization) 也叫离差标准化,是对原始数据的线性变换,使结果落到[0,1]区间,转换函数如下:也称为离差标准化,是对原始数据的线性变换,使结果值映射到[0 - 1]之间。转换函数如下: 其中max为样本数据的最大值,min为样本数据的最小值。这种方法有个缺陷就是当有新数据加入时,可能导致max和min

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=252460, encodeId=18ef252460b6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 13 08:04:50 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252418, encodeId=7940252418b9, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 13 07:12:27 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252384, encodeId=b71a25238425, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Oct 13 06:14:20 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252346, encodeId=70a425234682, content=原始数据经过数据标准化处理后.各指标处于同一数量级.适合进行综合对比评价., beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Oct 12 23:13:34 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252334, encodeId=b26c252334ed, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Oct 12 22:52:09 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-13 Y—xianghai

    学习了新知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=252460, encodeId=18ef252460b6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 13 08:04:50 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252418, encodeId=7940252418b9, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 13 07:12:27 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252384, encodeId=b71a25238425, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Oct 13 06:14:20 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252346, encodeId=70a425234682, content=原始数据经过数据标准化处理后.各指标处于同一数量级.适合进行综合对比评价., beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Oct 12 23:13:34 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252334, encodeId=b26c252334ed, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Oct 12 22:52:09 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-13 明月清辉

    谢谢分享.学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=252460, encodeId=18ef252460b6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 13 08:04:50 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252418, encodeId=7940252418b9, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 13 07:12:27 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252384, encodeId=b71a25238425, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Oct 13 06:14:20 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252346, encodeId=70a425234682, content=原始数据经过数据标准化处理后.各指标处于同一数量级.适合进行综合对比评价., beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Oct 12 23:13:34 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252334, encodeId=b26c252334ed, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Oct 12 22:52:09 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-13 三生有幸9135

    学习一下谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=252460, encodeId=18ef252460b6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 13 08:04:50 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252418, encodeId=7940252418b9, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 13 07:12:27 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252384, encodeId=b71a25238425, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Oct 13 06:14:20 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252346, encodeId=70a425234682, content=原始数据经过数据标准化处理后.各指标处于同一数量级.适合进行综合对比评价., beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Oct 12 23:13:34 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252334, encodeId=b26c252334ed, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Oct 12 22:52:09 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-12 有备才能无患

    原始数据经过数据标准化处理后.各指标处于同一数量级.适合进行综合对比评价.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=252460, encodeId=18ef252460b6, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Oct 13 08:04:50 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252418, encodeId=7940252418b9, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Fri Oct 13 07:12:27 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252384, encodeId=b71a25238425, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri Oct 13 06:14:20 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252346, encodeId=70a425234682, content=原始数据经过数据标准化处理后.各指标处于同一数量级.适合进行综合对比评价., beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu Oct 12 23:13:34 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252334, encodeId=b26c252334ed, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Thu Oct 12 22:52:09 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-12 惠映实验室

    学习了.谢谢.

    0

相关资讯

“马赛克疫苗使HIV灭绝”系误读 数据源自动物试验

据中国之声《新闻晚高峰》报道,8月10日,有媒体报道或是转载了一篇有关人类免疫缺陷病毒HIV疫苗,即艾滋病病毒疫苗研究进展的内容,称某公司“在今年7月24日宣布了全球首次HIV疫苗人体临床试验结果。结果显示,被试志愿者对HIV疫苗耐受性良好”。当中,还列举了一些数据,例如,“100%产生了对抗HIV的抗体”“受试者单次暴露于艾滋病病毒下的感染风险减少了94%”。

NATURE新闻:数据公开后的烦恼,20篇论文可能被人抢发!

一家知名医学期刊举办了一场竞赛,邀请科学家对一项有关血压的关键性临床研究的数据展开分析,探索新发现。来自全球各地的数百位研究者竞相报名参加。

男人患帕金森风险是女人1.46倍!宣武李勇杰报告“大数据”

首都医科大学宣武医院功能神经外科主任、北京功能神外研究所所长李勇杰教授近日做了关于《立体定向手术治疗运行障碍病-宣武医院20年工作回顾性研究》的学术报告。在过去的20年中,李勇杰教授团队积累了世界最大宗运动障碍病手术量,共完成手术治疗6467例,李勇杰教授的报告公布了基于这份数据的研究与分析,是难得的运动障碍病外科治疗“大数据”。

临床试验中缺失数据的预防与处理

缺失数据在临床试验中是非常常见且不可避免的。它一般是由于受试者在试验中失访、依从性差、不良事件、缺乏疗效等原因提前退出试验而造成,也可能是因为采集标本或测量中的问题,如疫苗临床试验中因采取的血液样本过少而未能检测到有效的抗体滴度值所造成的疗效指标缺失等。缺失数据不仅会降低试验的把握度,而且会给试验结果的评价带来偏倚。因此,一方面,在数据统计分析时,采用适当的统计分析方法提高试验的检验效能,减小

结核病日:看看带泥土味的结核病研究数据是怎么做出来的

3月24日是世界防治结核病日,结核病是全球十大死因之一,严重威胁着人类健康。在控制结核病的征程上,科研人员从未停步,他们用带着泥土味的研究数据努力书写中国结核病防治的未来之路。

生物样本数据难共享 精准医疗须突破数据瓶颈

为患者量身设计最佳治疗方案,精准医疗将带领医学进入一个新时代。我国的精准医疗经过几年的摸爬滚打,如今正遭遇“数据瓶颈”。日前,在沪上举行的精准医学发展战略高端学术论坛上,各路专家呼吁数据科学家与生命科学家、医学家联手,共同突破这一瓶颈,让中国的精准医疗发展驶入快车道。生物医学大数据:增速最快,难题最多早在本世纪初,中国医学界就开始关注精准医疗。经过多年的实践,“一定要有中国人群数据”已经成为生命科